Q2 2026 · Form 13F Ledger数据来源:SEC EDGAR  
H

HOLDER.TOP

谁持有什么——美股机构持仓的季度账本。
EN · 简 · 繁
机构 / Defilade Capital Management, L.P.
Form 13F · Q2 2026

Defilade Capital Management, L.P.

CIK 2088557申报日 2026-08-1413F-HR 在 EDGAR 查看原始申报 ↗
$7.5亿
申报组合市值
39
持仓数量
3
Quarters on record
Top 50
持仓数量

Defilade Capital Management, L.P.——持仓

共 39 个持仓中的前 39 名,按申报市值排名。股数变动与上一季度对比。
#证券股数股数环比市值占其组合
1LLY Eli Lilly & Co39,086+88.9%$4688万6.3%
2PFE Pfizer Inc1.8M+21.0%$4266万5.7%
3VEEV Veeva Sys Inc236,709—$4201万5.6%
4BMRN Biomarin Pharmaceutical Inc682,005—$3902万5.2%
5PTCT Ptc Therapeutics Inc433,699+15.3%$3538万4.7%
6BAX Baxter Intl Inc1.5M—$3111万4.2%
7INSM Insmed Inc281,838+44.6%$3005万4.0%
8ZBH Zimmer Biomet Holdings Inc317,426−45.2%$2733万3.7%
9PODD Insulet Corp176,932—$2694万3.6%
10TMO Thermo Fisher Scientific Inc51,934—$2604万3.5%
11ABT Abbott Laboratories285,778—$2593万3.5%
12ASND Ascendis Pharma A/S94,843—$2530万3.4%
13SOLV Solventum Corp316,454—$2441万3.3%
14MDT Medtronic Plc303,301—$2373万3.2%
15ELAN Elanco Animal Health Inc864,080−7.2%$2127万2.8%
16AGIO Agios Pharmaceuticals Inc546,848—$2029万2.7%
17NVST Envista Holdings Corporation726,108—$1913万2.6%
18RVMD Revolution Medicines Inc82,827−73.8%$1551万2.1%
19ICUI Icu Med Inc105,700−58.4%$1550万2.1%
20COGT Cogent Biosciences Inc393,441+11.6%$1523万2.0%
21LNTH Lantheus Hldgs Inc132,662−46.8%$1472万2.0%
22OCUL Ocular Therapeutix Inc1.5M+0.2%$1463万2.0%
23ELDN Eledon Pharmaceuticals Inc3.5M−1.1%$1389万1.9%
24TYRA Tyra Biosciences Inc376,870—$1204万1.6%
25OLEMA PHARMACEUTICALS INC Olema Pharmaceuticals Inc924,758−38.5%$1157万1.5%
26ORIC Oric Pharmaceuticals Inc1.0M+24.3%$1135万1.5%
27LRMR Larimar Therapeutics Inc3.7M—$1119万1.5%
28GMED Globus Med Inc139,637−60.6%$1103万1.5%
29ENOV Enovis Corporation531,945—$1101万1.5%
30EVMN Evommune Inc793,145+16.9%$1054万1.4%
31TFX Teleflex Incorporated80,118—$1016万1.4%
32DNLI Denali Therapeutics Inc391,866−71.2%$1008万1.3%
33GKOS Glaukos Corp66,519—$930万1.2%
34STAA Staar Surgical Co322,126—$924万1.2%
35PACS Pacs Group Inc215,675−64.3%$920万1.2%
36CRINETICS PHARMACEUTICALS IN Crinetics Pharmaceuticals In239,440—$896万1.2%
37LIVN Livanova Plc107,373—$883万1.2%
38BDTX Black Diamond Therapeutics I1.7M—$310万0.4%
39MREO Mereo Biopharma Group Plc7.6M+0.0%$240万0.3%
来源:经 SEC EDGAR 的 Form 13F 申报。持仓截至 2026 年 6 月 30 日。期权(看涨/看跌)不计入股数。